Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
JYSB2000423	注射用阿替普酶	alteplase	Lyophilized	Biological Products	Supplementary Application	2020-08-31	勃林格殷格翰（中国）投资有限公司	Boehringer Ingelheim (China) Investment Co Ltd;Boehringer Ingelheim Pharma Gmbh & Co KG	Filed	2020-09-11	view
JYSB2000422	注射用阿替普酶	alteplase	Lyophilized	Biological Products	Supplementary Application	2020-08-31	勃林格殷格翰（中国）投资有限公司	Boehringer Ingelheim (China) Investment Co Ltd;Boehringer Ingelheim Pharma Gmbh & Co KG	Filed	2020-09-11	view
JYSB1400115	注射用阿替普酶	alteplase	Lyophilized	Biological Products	Supplementary Application	2014-08-14	勃林格殷格翰国际贸易（上海）有限公司	Boehringer Ingelheim International Trading (Shanghai) Co Ltd;Boehringer Ingelheim Pharma Gmbh & Co KG	Certificate Issued	2015-01-15	view
JYSB1400116	注射用阿替普酶	alteplase	Lyophilized	Biological Products	Supplementary Application	2014-08-14	勃林格殷格翰国际贸易（上海）有限公司	Boehringer Ingelheim International Trading (Shanghai) Co Ltd;Boehringer Ingelheim Pharma Gmbh & Co KG	Certificate Issued	2015-01-15	view
JYSB1300207	注射用阿替普酶	alteplase	Lyophilized	Biological Products	Supplementary Application	2013-08-28	勃林格殷格翰国际贸易（上海）有限公司	Boehringer Ingelheim International Trading (Shanghai) Co Ltd;Boehringer Ingelheim Pharma Gmbh & Co KG	Certificate Issued	2014-06-17	view
JYSB1300208	注射用阿替普酶	alteplase	Lyophilized	Biological Products	Supplementary Application	2013-08-28	勃林格殷格翰国际贸易（上海）有限公司	Boehringer Ingelheim International Trading (Shanghai) Co Ltd;Boehringer Ingelheim Pharma Gmbh & Co KG	Certificate Issued	2014-06-17	view
JYSB1900366	注射用阿替普酶	alteplase	Lyophilized	Biological Products	Supplementary Application	2020-01-03	勃林格殷格翰(中国)投资有限公司	Boehringer Ingelheim (China) Investment Co Ltd;Boehringer Ingelheim Pharma Gmbh & Co KG	Filed	2020-01-08	view
JYSB1700169	注射用阿替普酶	alteplase	Lyophilized	Biological Products	Supplementary Application	2017-10-20	勃林格殷格翰(中国)投资有限公司	Boehringer Ingelheim (China) Investment Co Ltd;Boehringer Ingelheim Pharma Gmbh & Co KG	Certificate Issued	2019-12-23	view
JYSB1800119	注射用阿替普酶	alteplase	Lyophilized	Biological Products	Supplementary Application	2018-06-04	勃林格殷格翰(中国)投资有限公司	Boehringer Ingelheim (China) Investment Co Ltd;Boehringer Ingelheim Pharma Gmbh & Co KG	Certificate Issued	2019-11-28	view
JYSZ1500004	注射用阿替普酶	alteplase	Lyophilized	Biological Products	License Renew	2015-02-26	勃林格殷格翰(中国)投资有限公司	Boehringer Ingelheim (China) Investment Co Ltd;Boehringer Ingelheim Pharma Gmbh & Co KG	Certificate Issued	2016-12-08	view
JYSB1800098	注射用阿替普酶	alteplase	Lyophilized	Biological Products	Supplementary Application	2018-05-14	勃林格殷格翰(中国)投资有限公司	Boehringer Ingelheim (China) Investment Co Ltd;Boehringer Ingelheim Pharma Gmbh & Co KG	Certificate Issued	2021-02-02	view
JYSB1700170	注射用阿替普酶	alteplase	Lyophilized	Biological Products	Supplementary Application	2017-10-20	勃林格殷格翰(中国)投资有限公司	Boehringer Ingelheim (China) Investment Co Ltd;Boehringer Ingelheim Pharma Gmbh & Co KG	Certificate Issued	2019-12-23	view
JYSB1800118	注射用阿替普酶	alteplase	Lyophilized	Biological Products	Supplementary Application	2018-06-04	勃林格殷格翰(中国)投资有限公司	Boehringer Ingelheim (China) Investment Co Ltd;Boehringer Ingelheim Pharma Gmbh & Co KG	Certificate Issued	2019-11-28	view
JYSZ1500003	注射用阿替普酶	alteplase	Lyophilized	Biological Products	License Renew	2015-02-11	勃林格殷格翰(中国)投资有限公司	Boehringer Ingelheim (China) Investment Co Ltd;Boehringer Ingelheim Pharma Gmbh & Co KG	Certificate Issued	2016-12-08	view
JYSB1800096	注射用阿替普酶	alteplase	Lyophilized	Biological Products	Supplementary Application	2018-05-14	勃林格殷格翰(中国)投资有限公司	Boehringer Ingelheim (China) Investment Co Ltd;Boehringer Ingelheim Pharma Gmbh & Co KG	Certificate Issued	2021-02-02	view
JYSB1900367	注射用阿替普酶	alteplase	Lyophilized	Biological Products	Supplementary Application	2020-01-03	勃林格殷格翰(中国)投资有限公司	Boehringer Ingelheim (China) Investment Co Ltd;Boehringer Ingelheim Pharma Gmbh & Co KG	Filed	2020-01-08	view
JYSB1800095	注射用阿替普酶	alteplase	Lyophilized	Biological Products	Supplementary Application	2018-05-14	勃林格殷格翰(中国)投资有限公司	Boehringer Ingelheim (China) Investment Co Ltd;Boehringer Ingelheim Pharma Gmbh & Co KG	Certificate Issued	2018-09-19	view
JYSB2000001	注射用阿替普酶	alteplase	Lyophilized	Biological Products	Supplementary Application	2020-02-03	勃林格殷格翰(中国)投资有限公司	Boehringer Ingelheim (China) Investment Co Ltd;Boehringer Ingelheim Pharma Gmbh & Co KG	Certificate Issued	2021-08-31	view
JYSB1400248	注射用阿替普酶	alteplase	Lyophilized	Biological Products	Supplementary Application	2014-12-10	勃林格殷格翰(中国)投资有限公司	Boehringer Ingelheim (China) Investment Co Ltd;Boehringer Ingelheim Pharma Gmbh & Co KG	Certificate Issued	2016-12-08	view
JYSB1800002	注射用阿替普酶	alteplase	Lyophilized	Biological Products	Supplementary Application	2018-01-26	勃林格殷格翰(中国)投资有限公司	Boehringer Ingelheim (China) Investment Co Ltd;Boehringer Ingelheim Pharma Gmbh & Co KG	Certificate Issued	2019-08-05	view